Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Landos Biopharma, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +5 vs. Q3 2021
- Shares held
- 24.9M
- +2.27M (+10.0%) vs. Q3 2021
- Total value
- $119.8M
- −$211.3M (−63.8%) vs. Q3 2021
- New holders
- 11
- 12 more added
- Sold out
- 6
- 7 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LABP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 16 | $34.9M |
| Q4 2023 | 10 | $5.58M |
| Q3 2023 | 11 | $5.93M |
| Q2 2023 | 8 | $6.27M |
| Q1 2023 | 20 | $4.63M |
| Q4 2022 | 23 | $7.87M |
| Q3 2022 | 31 | $14.0M |
| Q2 2022 | 35 | $16.4M |
| Q1 2022 | 45 | $35.3M |
| Q4 2021 | 40 | $119.8M |
| Q3 2021 | 35 | $331.1M |
| Q2 2021 | 33 | $261.4M |
| Q1 2021 | 47 | $218.9M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Landos Biopharma, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 14 | $0 | 0.00% | +14 | New |
| Ameritas Investment Partners, Inc. | 515 | $2.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 408 | $2.00K | 0.00% | 00.0% | Unchanged |
| Carroll Financial Associates, Inc. | 408 | $2.00K | 0.00% | +15+3.8% | Added |
| Manchester Capital Management LLC | 406 | $2.00K | 0.00% | +406 | New |
| California State Teachers Retirement System | 1,566 | $8.00K | 0.00% | −964−38.1% | Reduced |
| American International Group, Inc. | 2,487 | $12.0K | 0.00% | −76−3.0% | Reduced |
| Citigroup Inc | 2,448 | $12.0K | 0.00% | +1,900+346.7% | Added |
| New York State Common Retirement Fund | 2,741 | $13.0K | 0.00% | −15−0.5% | Reduced |
| Deutsche Bank AG | 2,843 | $14.0K | 0.00% | +150+5.6% | Added |
| UBS Group AG | 3,805 | $18.0K | 0.00% | +3,805 | New |
| Tower Research Capital LLC (TRC) | 3,972 | $19.0K | 0.00% | +3,320+509.2% | Added |
| Allworth Financial LP | 5,286 | $25.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 8,151 | $39.0K | 0.00% | +7,532+1,216.8% | Added |
| Acadian Asset Management LLC | 8,274 | $39.0K | 0.00% | +8,274 | New |
| STRS Ohio | 11,400 | $54.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 12,979 | $63.0K | 0.00% | −1,974−13.2% | Reduced |
| Charles Schwab Investment Management Inc | 13,960 | $68.0K | 0.00% | 00.0% | Unchanged |
| Jump Financial, LLC | 15,200 | $73.0K | 0.00% | +15,200 | New |
| Goldman Sachs Group Inc | 17,568 | $84.0K | 0.00% | +17,568 | New |
| Two Sigma Advisers, LP | 25,700 | $123.0K | 0.00% | +25,700 | New |
| Bank of America Corp | 31,225 | $150.0K | 0.00% | +29,739+2,001.3% | Added |
| Walleye Trading LLC | 43,279 | $208.0K | 0.00% | +43,279 | New |
| Northern Trust Corp | 46,007 | $221.0K | 0.00% | −673−1.4% | Reduced |
| Two Sigma Investments, LP | 54,778 | $263.0K | 0.00% | +54,778 | New |
| Walleye Capital LLC | 105,208 | $505.0K | 0.02% | +105,208 | New |
| State Street Corp | 107,596 | $516.0K | 0.00% | +300.0% | Added |
| Geode Capital Management, LLC | 113,924 | $546.0K | 0.00% | +991+0.9% | Added |
| Botty Investors LLC | 128,750 | $618.0K | 0.18% | 00.0% | Unchanged |
| Macquarie Group Ltd | 147,182 | $706.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 153,776 | $738.0K | 0.00% | +152,033+8,722.5% | Added |
| Renaissance Technologies LLC | 171,100 | $821.0K | 0.00% | +160,200+1,469.7% | Added |
| OrbiMed Advisors LLC | 283,217 | $1.36M | 0.02% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 299,616 | $1.44M | 0.00% | −10,376−3.3% | Reduced |
| Vanguard Group Inc | 304,798 | $1.46M | 0.00% | +40.0% | Added |
| BlackRock Inc. | 470,428 | $2.26M | 0.00% | +236,812+101.4% | Added |
| Logos Global Management LP | 1,375,000 | $6.60M | 0.68% | −30,000−2.1% | Reduced |
| OUP Management Co., LLC | 1,827,478 | $8.77M | 3.95% | +1,827,478 | New |
| RTW Investments, LP | 4,275,722 | $20.5M | 0.30% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 14,869,915 | $71.4M | 1.10% | 00.0% | Unchanged |
| Woodline Partners LP | 0 | $0 | 0.00% | −212,800−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −18,831−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −18,174−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Cahill Financial Advisors Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |